BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH
Patent Applications and Registrations
Patent applications and USPTO patent grants for BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH.The latest application filed is for "a method of reducing brain amyloid plaques using anti-ab antibodies".
- BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH - Schlieren CH
| Patent | Date |
|---|---|
| A Method Of Reducing Brain Amyloid Plaques Using Anti-ab Antibodies App 20150315267 - Bussiere; Thierry ; et al. | 2015-11-05 |
| Human Anti-alpha-synuclein Antibodies App 20150232542 - WEIHOFEN; Andreas ; et al. | 2015-08-20 |
| Human anti-tau antibodies Grant 8,940,272 - Nitsch , et al. January 27, 2 | 2015-01-27 |
| Human anti-alpha-synuclein antibodies Grant 8,940,276 - Weihofen , et al. January 27, 2 | 2015-01-27 |
| USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAIN App 20140295465 - Weihofen; Andreas ; et al. | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 